Clinical trials
Bioequivalence clinical trials
Below are recruiting bioequivalence clinical trials, each written for real people, not researchers. We’re tracking 19 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07096869RecruitingPhase 1
Breast cancer trial comparing two forms of paclitaxel
This study checks if a generic version of paclitaxel protein-bound particles works the same as the brand-name drug in people with breast cancer. It's for patients whose cancer has spread or returned, and who might benefit from this medicine alone.
Changchun, JilinAges 18–75 - NCT07756996RecruitingPhase 1
How a new depression pill is absorbed in the body
This study tests whether a new version of an antidepressant pill is absorbed the same way as the existing one, and whether food changes how it is absorbed. Participants take the pill and have blood tests to measure drug levels.
Suzhou, JiangsuAges 18–65 - NCT07355738RecruitingPhase 1
Bioequivalence study of GZR18 injection
This study tests whether a change in the manufacturing process for GZR18 (an experimental injectable drug) affects how it works in the body. It may help determine if the new version is as safe and effective as the original.
Suzhou, SuzhouAges 18–50 - NCT07643220RecruitingPhase 1
Comparing Two Versions of a Hair-Loss Medication
This study tests whether two versions of the same medication (AJU-G721 and G721R)—used to treat hair loss and urinary symptoms—work the same way in the body. Researchers will measure how much medication gets absorbed and how long it stays in your system.
SeoulAges 19–54 - NCT05401357RecruitingPhase 3
Test eye drops for glaucoma or high eye pressure in both eyes
This Phase 3 study compares two versions of the same glaucoma eye-drop medicine (bimatoprost 0.01%) to see how similarly they work and their effect on eye pressure. It may help people with chronic open-angle glaucoma or ocular hypertension who need treatment in both eyes.
Newport Beach, CaliforniaAges 18 years+ - NCT06267274RecruitingPhase 1
Comparing two forms of bimatoprost for glaucoma or high eye pressure
This trial tests whether a new formulation of bimatoprost works as well as an existing one to lower eye pressure in people with chronic open-angle glaucoma or ocular hypertension. It involves multiple eye drop doses and checks for safety and effectiveness.
Bakersfield, CaliforniaAges 18 years+ - NCT06683066RecruitingPhase 1
Testing a prostate cancer drug for bioequivalence
This trial checks if a new version of the prostate cancer drug triprerelin works the same as the current one. It may be an option for men with prostate cancer who need hormone therapy.
Qingdao, ShandongAges 18 years+ - NCT06765590Recruiting
Paclitaxel (albumin-bound) bioequivalence study in breast cancer
This study tests whether a new version of paclitaxel (albumin-bound) works the same as the approved version in people with breast cancer. It's for patients whose cancer has spread or returned after other treatments, or those for whom this drug is recommended by treatment guidelines.
Luoyang, HenanAges 18–75 - NCT07069335RecruitingPhase 1
Studying a new form of olaparib for BRCA-mutated ovarian cancer
This study tests a new form of a drug similar to olaparib (Lynparza) in people with BRCA-mutated ovarian cancer. It looks at how the drug works in the body and checks for safety, to see if the new formulation is as effective and safe as the current one.
Seoul, Songpa DistrictAges 19–74 - NCT07260851RecruitingPhase 1
Comparing three versions of an experimental drug in healthy volunteers
This trial tests three different formulations of an experimental drug in healthy volunteers to see if they work the same way in the body. It is a first step to ensure the drug is safe before testing in patients.
Seoul, Gwanak-guAges 19 years+ - NCT07267221RecruitingPhase 1
Comparing three versions of a drug in healthy people after a meal
This trial checks how three different versions of a medication (DWC202313, DWC202314, and DWJ1622) are absorbed by the body when taken with food. Healthy volunteers take the drugs once and have blood drawn over time to compare safety and how the drugs move through the body.
Seoul, Gwanak-guAges 19 years+ - NCT07371104RecruitingPhase 1
Study of DWZ2501 in advanced BRCA ovarian cancer on olaparib
This trial compares how the body processes a new formulation of olaparib (DWZ2501) versus the standard version. It is for women with advanced, BRCA-mutated high-grade ovarian cancer who are already on or about to start a stable dose of olaparib 300 mg twice daily.
Seoul, Jongno-guAges 19 years+ - NCT07382908RecruitingPhase 1
Bioequivalence study of an injection for weight management
This trial tests if a new injection works the same as the approved version in overweight or obese adults. It may help if you are looking for a weight management treatment.
Hangzhou, ZhejiangAges 18–55 - NCT07421011RecruitingPhase 1
Comparing two forms of a drug for healthy volunteers
This study tests two different versions of a drug called Trimedat to see if they work the same way in the body. It is for healthy volunteers to understand how the drug is absorbed and if it is safe.
Saint PetersburgAges 18–45 - NCT07493551Recruiting
Bioequivalence study of a long-acting injection for schizophrenia
This trial tests whether a new version of an extended-release injection is as effective as the original in people with schizophrenia. The study helps ensure patients have access to a reliable treatment option.
Beijing, Beijing MunicipalityAges 18–65 - NCT07606105RecruitingPhase 1
Iron Injection Safety and Effectiveness Study in Healthy Adults
This study tests a new iron injection medication in healthy people to ensure it works the same way as a reference version. Participants will receive the injection while fasting and undergo blood tests to measure how the body processes the iron.
JinanAges 18–55 - NCT07610005RecruitingPhase 1
Varegacestat dosing study in healthy adults
This early-stage study tests how the body absorbs and processes a new drug called varegacestat in healthy people. Researchers will compare different ways of giving the drug to understand how well it works.
Tempe, ArizonaAges 18–55 - NCT07611929Recruiting
Body composition changes during progesterone gel study
This study measures how your body composition (muscle, fat, water) changes while you're taking part in a progesterone gel trial. Researchers want to understand how the body's makeup relates to how the medication works in your system.
Wenzhou, ZhejiangAges 18–65 - NCT06762743Enrolling by invitationPhase 1
Comparing two brivaracetam oral solutions in healthy adults
This study tests whether two different forms of an oral solution of brivaracetam (a seizure medication) have the same effect in the body. Healthy adults take one dose and have blood samples collected—first on an empty stomach, and later after a high-fat meal—to compare how the drug is absorbed.
Nanjing, JiangsuAges 18–55
Hear when a new Bioequivalence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bioequivalence?
- Yes. Clin2 currently lists 19 recruiting bioequivalence studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bioequivalence trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bioequivalence trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.